Orthopedics News and Research RSS Feed - Orthopedics News and Research

Thyroxine may overcome mutated thyroid hormone receptor effects

Thyroxine may overcome mutated thyroid hormone receptor effects

Patients with a mutation in the thyroid hormone receptor α gene that affects both the thyroid hormone receptor α1 and α2 protein variants have similar characteristics to patients with mutations affecting only the α1 variant, report researchers. [More]
Seattle magazine names 36 EvergreenHealth physicians to "Top Doctors" list

Seattle magazine names 36 EvergreenHealth physicians to "Top Doctors" list

The latest issue of Seattle magazine names 36 physicians within the EvergreenHealth network to the publication's annual "Top Doctors" list. [More]
Genetic variants alter chance of sunitinib dose reduction

Genetic variants alter chance of sunitinib dose reduction

Scientists have identified genetic variants that reduce the likelihood of sunitinib dose reduction in patients with metastatic renal cell carcinoma. [More]
Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Wheaton Franciscan Healthcare-Iowa is the latest to deploy TRU-D SmartUVC, a 5-foot-5 germ-killing ultraviolet robot equipped with the only infection prevention data collection and reporting software on the market. TRU-D is now in use at Covenant Medical Center in Waterloo and Sartori Medical Center in Cedar Falls, Iowa. [More]

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million. [More]
FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

Thermedx, LLC, an innovative designer and manufacturer of "smart" surgical irrigation products, received FDA 510(k) clearance for optional fluid warming in arthroscopic and hysteroscopic procedures. [More]
New smartphone app can reduce sedentary behavior in obese adults

New smartphone app can reduce sedentary behavior in obese adults

Even individuals who exercise a lot can be at risk for health problems if they also spend a lot of time in sedentary behaviors, such as sitting. [More]
Auxilium Pharmaceuticals plans to merge with QLT

Auxilium Pharmaceuticals plans to merge with QLT

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, and QLT Inc., a Canadian-based biotechnology company focused on developing innovative orphan ophthalmology products, today announced that they have entered into a definitive agreement under which Auxilium plans to merge with QLT. [More]
Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Arcam, listed on NASDAQ OMX, has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants. [More]
Six-gene signature predicts survival after targeted therapy for NSCLC

Six-gene signature predicts survival after targeted therapy for NSCLC

The presence of a six-gene profile in the microRNA of patients with advanced non-squamous non-small-cell lung cancer predicts reduced survival likelihood after first-line treatment with targeted therapy followed by chemotherapy for disease progression, indicate research results. [More]
FGFR1 amplification predicts poor outcome in early-stage NSCLC

FGFR1 amplification predicts poor outcome in early-stage NSCLC

Amplification of fibroblast growth factor receptor 1 is associated with poor clinical outcome in patients with early-stage non-small-cell lung cancer, Swiss researchers report. [More]
SCLC tumours replicated in mice from patients' CTCs

SCLC tumours replicated in mice from patients' CTCs

Scientists have used circulating tumour cells taken from patients with small-cell lung cancer to grow explant tumours in mice that retain the original’s morphological and genetic characteristics. [More]
Greenlander study identifies single mutation with large diabetes risk

Greenlander study identifies single mutation with large diabetes risk

Researchers have used a Greenlandic cohort to identify a genetic mutation whose effect on the risk of diabetes is “several times larger” than any previously discovered. [More]
Symbion and Surgery Partners sign definitive merger agreement

Symbion and Surgery Partners sign definitive merger agreement

Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million. [More]
Greenwood Genetic and Clemson receive first round of fund from SRHC

Greenwood Genetic and Clemson receive first round of fund from SRHC

Seven research projects from Greenwood Genetic Center and Clemson University faculty were selected to receive the first round of funding provided by Self Regional Healthcare (SRHC). [More]
Sutter Health invests $11.5M to install patient safety equipment across Northern California

Sutter Health invests $11.5M to install patient safety equipment across Northern California

Today, not-for-profit Sutter Health announces an $11.5 million commitment to install overhead patient lifts at 19 intensive care units and acute rehabilitation centers across its Northern California network. [More]
Auxilium and Prasco introduce authorized generic version of Testim

Auxilium and Prasco introduce authorized generic version of Testim

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that it has partnered with Prasco, LLC ("Prasco") to introduce an Authorized Generic version of Testim® (testosterone gel). [More]
UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

More than one hospital television drama has played out an emergency room scene where a patient has to be "tubed" to re-establish breathing. [More]
Adding evidence-based weight loss strategies enhances statewide wellness campaign

Adding evidence-based weight loss strategies enhances statewide wellness campaign

Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health. [More]
Banner Health receives prestigious stroke award

Banner Health receives prestigious stroke award

Several Banner Health facilities in Arizona have received a prestigious stroke award in recognition of their ability to better diagnose and treat stroke patients, to reduce death and disability among patients and to speed recovery. [More]